NCT06044519

A Single Center Trial of Donor Site Wound Dressings After Split Thickness Skin Grafting.

A Single Centre Randomized Control Trial of Donor Site Wound Dressing After Split Thickness Skin Grafting

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Dow University of Health Sciences · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical trial\] is to compare different types of dressings used and there outcomes on STSG donor site wound. The main question\[s\] it aims to answer are: * the effectiveness of different donor site dressings and their adverse outcomes * the satisfaction of patients with the donor site dressing will be observed. Participants will randomly allocated different types of dressings for split thickness skin graft donor site wound which include alginate hydrocolloid hydrofiber silicon film guaze

Conditions

• Donor Site Complication
• Skin Graft Scar

Interventions

Type	Name	Description
BIOLOGICAL	different types of dressings	different types of dressings were compared ti see the effectiveness for for STSG donor site wound

Timeline

• Start date: 2022-08-01
• Primary completion: 2023-02-28
• Completion: 2023-02-28
• First posted: 2023-09-21
• Last updated: 2023-09-21

Locations

1 site across 1 country: Pakistan

Regulatory

• FDA-regulated drug study